Pharmacology of sympathomimetic amines with beta-adrenoreceptor agonist and alpha-adrenoreceptor antagonist properties.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000818:Animals; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation; D004983:Ethanolamines / Q000494:pharmacology; D005260:Female; D006168:Guinea Pigs; D006325:Heart Atria / Q000187:drug effects; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D009025:Morpholines / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D013329:Structure-Activity Relationship; D013566:Sympathomimetics / Q000494:pharmacology*; D014132:Trachea / Q000187:drug effects; D014649:Vas Deferens / Q000187:drug effects
D000317:Adrenergic alpha-Antagonists; D000318:Adrenergic beta-Agonists; D004983:Ethanolamines; D009025:Morpholines; D013566:Sympathomimetics; D011433:Propranolol; D007545:Isoproterenol